The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.
When the FDA was deciding whether to approve the drug Tavneos several years ago to treat a set of rare autoimmune diseases, agency experts argued that would be a mistake, according to FDA records. One […]